Physician profile
Treven Rollins
NPI 1841491255
$701.30
in general payments reported to CMS, 2019-2025
7 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.19 · 2020: $82.55 · 2021: $15.00 · 2023: $124 · 2024: $252 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.56 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightforce Orthodontics, INC. | $275.53 | 2023-2025 | |
| Align Technology, INC. | $153.66 | 2019-2025 | Invisalign Touch Up, Invisalign, Itero |
| American Orthodontics Corporation | $119.73 | 2019-2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| USA Angelalign Technology Corp | $75.15 | 2024-2025 | |
| Dentsply Sirona INC | $38.46 | 2020 | |
| World Class Technology Corporation | $20.19 | 2019 | |
| Solventum Corporation | $18.58 | 2024 | Apc II Unitek Gemini, Clarity Aligners, Transbond Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Treven Rollins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.